DK0884308T3 - Fremgangsmåde til at fremstille 16-dehydro vitamin D forbindelser - Google Patents
Fremgangsmåde til at fremstille 16-dehydro vitamin D forbindelserInfo
- Publication number
- DK0884308T3 DK0884308T3 DK98201381T DK98201381T DK0884308T3 DK 0884308 T3 DK0884308 T3 DK 0884308T3 DK 98201381 T DK98201381 T DK 98201381T DK 98201381 T DK98201381 T DK 98201381T DK 0884308 T3 DK0884308 T3 DK 0884308T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- alkyl
- hydrogen
- group
- cycloalkyl
- Prior art date
Links
- 229930003316 Vitamin D Natural products 0.000 title abstract 2
- -1 Vitamin D Compounds Chemical class 0.000 title abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title abstract 2
- 235000019166 vitamin D Nutrition 0.000 title abstract 2
- 239000011710 vitamin D Substances 0.000 title abstract 2
- 229940046008 vitamin d Drugs 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97201334 | 1997-05-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0884308T3 true DK0884308T3 (da) | 2003-07-21 |
Family
ID=8228295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98201381T DK0884308T3 (da) | 1997-05-02 | 1998-04-28 | Fremgangsmåde til at fremstille 16-dehydro vitamin D forbindelser |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6080878A (de) |
| EP (1) | EP0884308B1 (de) |
| JP (1) | JPH10316652A (de) |
| AT (1) | ATE237586T1 (de) |
| DE (1) | DE69813380T2 (de) |
| DK (1) | DK0884308T3 (de) |
| ES (1) | ES2196476T3 (de) |
| IL (1) | IL124284A (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8404667B2 (en) * | 2006-12-29 | 2013-03-26 | Wisconsin Alumni Research Foundation | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog |
| US9221753B2 (en) | 2004-02-03 | 2015-12-29 | Chugai Seiyaku Kabushiki Kaisha | Process for the synthesis of vitamin D compounds and intermediates for the synthesis of the compounds |
| KR20170096238A (ko) * | 2009-01-27 | 2017-08-23 | 베르그 엘엘씨 | 화학요법과 연관된 부작용을 경감시키기 위한 비타민 ｄ３ 및 이의 유사물 |
| WO2011002756A2 (en) * | 2009-07-01 | 2011-01-06 | Vitamin Derivatives, Inc. | Vitamin d compounds and methods for preparing same |
| JP5978130B2 (ja) | 2009-08-14 | 2016-08-24 | バーグ エルエルシー | 脱毛症を治療するためのビタミンｄ３およびその類似体 |
| ES2396524B2 (es) * | 2012-12-11 | 2013-08-01 | Universidade De Santiago De Compostela | Intermedios versátiles y funcionalizados en la síntesis de vitamina D y nuevos derivados de vitamina D |
| EP3003497B1 (de) | 2013-05-29 | 2024-02-14 | BPGbio, Inc. | Verhinderung oder verringerung von chemotherapieinduzierter alopezie mit vitamin d |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA8923B (en) * | 1988-01-20 | 1989-09-27 | Hoffmann La Roche | 16-dehydro-vitamin d3-derivatives |
| DK0398217T3 (da) * | 1989-05-18 | 1994-02-14 | Hoffmann La Roche | Dehydrocholecalciferolderivater |
| TW267161B (de) * | 1992-11-20 | 1996-01-01 | Hoffmann La Roche | |
| US5401733A (en) * | 1993-10-01 | 1995-03-28 | Hoffmann-La Roche Inc. | Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol |
| DE59409642D1 (de) * | 1993-11-24 | 2001-03-01 | Targor Gmbh | Metallocene, Verfahren zu ihrer Herstellung und ihrer Verwendung als Katalysatoren |
| US5428029A (en) * | 1993-11-24 | 1995-06-27 | Hoffmann-La Roche Inc. | Vitamin D3 fluorinated analogs |
| US5384314B1 (en) * | 1994-03-11 | 1997-08-05 | Hoffmann La Roche | 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol |
| DE69508895T2 (de) * | 1994-12-14 | 1999-10-21 | Duphar Int Res | Vitamin-D-Derivate und Verfahren zur Herstellung dieser Verbindungen |
-
1998
- 1998-04-28 ES ES98201381T patent/ES2196476T3/es not_active Expired - Lifetime
- 1998-04-28 DK DK98201381T patent/DK0884308T3/da active
- 1998-04-28 EP EP98201381A patent/EP0884308B1/de not_active Expired - Lifetime
- 1998-04-28 DE DE69813380T patent/DE69813380T2/de not_active Expired - Fee Related
- 1998-04-28 AT AT98201381T patent/ATE237586T1/de not_active IP Right Cessation
- 1998-04-28 JP JP10132611A patent/JPH10316652A/ja active Pending
- 1998-04-29 IL IL12428498A patent/IL124284A/en not_active IP Right Cessation
- 1998-04-29 US US09/067,903 patent/US6080878A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10316652A (ja) | 1998-12-02 |
| ATE237586T1 (de) | 2003-05-15 |
| DE69813380T2 (de) | 2003-12-04 |
| US6080878A (en) | 2000-06-27 |
| DE69813380D1 (de) | 2003-05-22 |
| EP0884308B1 (de) | 2003-04-16 |
| ES2196476T3 (es) | 2003-12-16 |
| EP0884308A2 (de) | 1998-12-16 |
| EP0884308A3 (de) | 1999-05-19 |
| IL124284A (en) | 2004-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE263771T1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
| EA200200098A1 (ru) | Ароматические сложные эфиры для маркировки или мечения нефтепродуктов | |
| DK0884308T3 (da) | Fremgangsmåde til at fremstille 16-dehydro vitamin D forbindelser | |
| HK1001396A1 (en) | Pyrimidinylpyrazole derivative | |
| DE69724646D1 (de) | 16-ene-vitamin d derivate | |
| ES2190222T3 (es) | Derivados de 3-(2-oxo-(1,3')bipirrolindinil-3-iliden-metil)-cefem. | |
| DK41481A (da) | 2-nitro-5-(substitueret phenoxy)-benzoatestere af alfa-hydroxyalkanoater til anvendelse som herbicider | |
| FI950493A0 (fi) | Uudet tiatsiini- tai tiomorfoliinijohdannaiset | |
| DK0963998T3 (da) | Azasteroidforbindelse til behandling eller prævention af prostatacancer | |
| ATE111456T1 (de) | N-alkylthiazolidinderivate. | |
| DK61191A (da) | Fremgangsmaade til fremstilling af 1alfa-silyloxy-4alfa-hydroxy-3beta-(3alfa-hydroxy-4-phenoxy-buten-1-yl)-cyclopent-2alfa-yl-alkynderivater | |
| FI945762A (fi) | Uudet 3-okso-1,4-bentsotiatsiinijohdannaiset | |
| BR8804664A (pt) | Processo para a preparacao de um composto e compostos | |
| DE60000890T2 (de) | Verfahren zur Herstellung von 1,1,1-Trifluoro-2-aminoalkane |